| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Anand Sampath | EVP Ops Clinical Research | 2026-01-28 | 30,000 | $37.84 | $1.14MBuy |
| Anand Sampath | EVP Ops Clinical Research | 2026-01-28 | 196 | $138.09 | $27.07kSell |
| Anand Sampath | EVP Ops Clinical Research | 2026-01-28 | 6,560 | $137.22 | $900.16kSell |
| Anand Sampath | EVP Ops Clinical Research | 2026-01-28 | 11,924 | $136.56 | $1.63MSell |
| Omar Ahmed | CTIO EVP of Engineering | 2025-11-13 | 2,474 | $152.43 | $377.11kBuy |
| Blair Tripodi | COO Consumer Division | 2025-09-23 | 15,000 | $142.13 | $2.13MBuy |
| Michelle Brennan | Director | 2025-08-13 | 100 | $155.25 | $15.53kBuy |
| Michelle Brennan | Director | 2025-08-12 | 100 | $150.35 | $15.04kBuy |
| William R. Jellison | Director | 2025-08-11 | 3,000 | $145.98 | $437.94kBuy |
| Bilal Muhsin | Chief Operating Officer | 2025-05-12 | 10,000 | $34.51 | $345.10kBuy |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Blackrock Inc | 19.29% | 10,361,091 | $1.44B | Institution |
| Fmr LLC | 15.29% | 8,213,721 | $1.14B | Institution |
| Vanguard Group Inc | 8.95% | 4,810,011 | $669.31M | Institution |
| Politan Capital Management LP | 8.54% | 4,589,648 | $638.65M | Insider |
| Politan Capital Management LP | 8.54% | 4,589,648 | $638.65M | Institution |
| Joe E. Kiani | 6.01% | 3,226,230 | $448.93M | Insider |
| Massachusetts Financial Services Co | 4.88% | 2,619,960 | $364.57M | Institution |
| T Rowe Price Investment Management Inc | 3.96% | 2,126,763 | $295.94M | Institution |
| Capital Research Global Investors | 3.45% | 1,854,128 | $258.00M | Institution |
| State Street Corp | 2.76% | 1,484,471 | $206.56M | Institution |